We describe the molecular cloning of a receptor tyrosine kinase from a cell line (LK63) derived from a case of human pre-B-cell leukemia. We have previously shown that a monoclonal antibody (IIA4) raised against LK63 recognized a glycosylated, cell-surface 135-kDa molecule (HEK), which displayed tyrosine kinase activity in vitro. The (5), platelet-derived growth factor (6), colony-stimulating factor 1 (7), and stem cell factor (8). The recent isolation of lineagespecific (e.g., flk-2) (9) and developmentally regulated (e.g., CEK 5) (10) PTKs highlights an emerging role for this group of molecules in differentiation and development. As part of our study of human B-cell growth and differentiation, we have raised a number of monoclonal antibodies (mAbs) against early B-cell populations. One of these, designated IIIA4, has been shown to recognize a 135-kDa molecule (HEK) on the surface ofthe pre-B-cell leukemic cell line LK63 (11). Glycosylation studies demonstrated an estimated molecular mass of 95 kDa for the HEK core protein.
ABSTRACT
We describe the molecular cloning of a receptor tyrosine kinase from a cell line (LK63) derived from a case of human pre-B-cell leukemia. We have previously shown that a monoclonal antibody (IIA4) raised against LK63 recognized a glycosylated, cell-surface 135-kDa molecule (HEK), which displayed tyrosine kinase activity in vitro. The HEK protein was purified by using a 1A4 antibody column and both N-terminal and internal amino acid sequences were obtained. A 51-mer degenerate oligonucleotide based on the internal amino acid sequence was used to screen an LK63-derived AgtlO cDNA library under low-stringency hybridization conditions. One clone of2.5 kilobases (kb) was isolated and characterized and used to rescreen the library under morestringent hybridization conditions. A 4. Posttranslational phosphorylation of proteins constitutes an important regulatory mechanism for eukaryotic cells. For example, tyrosine phosphorylation of cdc2 is central to regulation of the cell cycle (1) . Kinases that phosphorylate proteins on tyrosine residues (protein tyrosine kinases; PTKs) form a structurally related group of molecules that exhibit functional diversity (2) . Genetic alterations that lead to the inappropriate activation or expression of PTKs may be oncogenic and have been associated with some human and murine tumors (3) . Some PTKs were first characterized as components of transforming retroviruses, with the subsequent identification of normal cellular counterparts (4) . The receptors for many of the known growth factors are PTKs, such as the receptors for epidermal growth factor (5), platelet-derived growth factor (6), colony-stimulating factor 1 (7), and stem cell factor (8) . The recent isolation of lineagespecific (e.g., flk-2) (9) and developmentally regulated (e.g., CEK 5) (10) PTKs highlights an emerging role for this group of molecules in differentiation and development. As part of our study of human B-cell growth and differentiation, we have raised a number of monoclonal antibodies (mAbs) against early B-cell populations. One of these, designated IIIA4, has been shown to recognize a 135-kDa molecule (HEK) on the surface ofthe pre-B-cell leukemic cell line LK63 (11) . Glycosylation studies demonstrated an estimated molecular mass of 95 kDa for the HEK core protein.
By indirect immunofluorescence, the human T-cell line JM also expressed this antigen, but a wide range of other lymphoid and myeloid cell lines were negative. Fluorescence-activated cell sorter analysis of normal human lymphoid and bone marrow cells showed no detectable HEK expression. However, HEK expression was observed on a small number of fresh hemopoietic tumor specimens, raising the possibility that IIIA4 recognized the product of a sporadically overexpressed gene. Immunoprecipitated HEK protein was shown to have tyrosine kinase activity in vitro. These data suggested that IIIA4 recognized a membraneassociated PTK. We used the IIIA4 mAb to affinity purify HEK protein from LK63 cells. Amino acid sequencing demonstrated a unique N terminus and PTK-related internal sequences.
In this report, we describe the isolation and sequence determination of a 4.5-kilobase (kb) cDNA encoding the HEK receptor tyrosine kinase (RTK) (13) . The 51-mer TA(C/T)CGICTICCICCICCIATGGA(C/T)TG(C/ T)CCIGCIGCICTITA(C/T)CA(A/G)CTIATG was endlabeled using [_y-32P]dATP and polynucleotide kinase, followed by separation on a G25 Sephadex column as described (14) . Approximately 250,000 plaques were screened in 2x SSC (lx SSC = 0.15 M NaCl/0.015 M sodium citrate) hybridization buffer at 37TC as described (14) . Washes were
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Proc. Natl. Acad. Sci. USA 89 (1992) performed in 2x SSC/0.1% SDS at 420C-550C. The signal from one duplicating plaque persisted after 550C washes. The DNA from this plaque contained an insert of 2.5 kb (HEK 2.5). HEK 2.5 was labeled with [a-32P]ATP (Amersham random primer kit) for Northern blot analysis of LK63 cells. The polymerase chain reaction (PCR) was performed using HEK 2.5 and oligonucleotide primers based on conserved motifs within the catalytic domain of PTKs and the 3' amino acid HEK sequence as described (15) . HEK 2.5 was labeled with [a-32P]ATP (as described above) and used to rescreen the random-primed LK63 cDNA library in 2x SSC hybridization buffer at 65TC. Thirty-two duplicating positives were isolated and screened by hybridization with a degenerate oligonucleotide based on the N-terminal HEK protein sequence. A 4.5-kb HEK clone (HEK 4.5), which hybridized with the N-terminal oligonucleotide, was chosen for complete characterization.
DNA Sequencing and Analysis of HEK cDNA. HEK 4.5 was subcloned into pGEM7, which had been digested with EcoRI and treated with calf intestinal alkaline phosphatase. used as the template in dideoxynucleotide chain-termination sequence reactions (16) . Sense and antisense oligonucleotide primers were used to complete sequencing with T7 DNA polymerase (Promega). Protein sequence alignment was performed using the GAP program (University of Wisconsin Genetics Computer Group).
Expression ofHEK in COS Cells. The HEK 4.5 EcoRI insert was blunt ended with Klenow DNA polymerase I and dATP plus TTP, followed by ligation to BstXI adaptors. The adapted insert was ligated to BstXI-digested CDM8 (17) . Sense and antisense constructs were prepared and transfected into COS cells using DEAE-dextran/chloroquine with dimethyl sulfoxide (17) . Two days posttransfection, COS cells were stained with IIIA4 followed by fluorescein isothiocyanate-conjugated sheep anti-mouse immunoglobulin (Silenus, Australia) and examined under a fluorescence microscope.
Northern and Southern Blot Analyses of Cell Lines. Poly(A)+-selected mRNA was isolated as described (18) and fractionated on a 1% formaldehyde agarose gel before transfer onto Hybond-C extra membrane (Amersham). Filters were probed with HEK 4.5 and subsequently with a glyceraldehyde-3-phosphate dehydrogenase insert as a control. DNA was prepared by lysis with guanidine hydrochloride (19) , transferred to Zetaprobe membrane, and hybridized under conditions suggested by the manufacturer (Bio-Rad).
To minimize cross-hybridization with other tyrosine kinases in Southern analysis of genomic DNA, PCR was used to generate a 1.1-kb HEK probe that spans a less highly conserved region of the molecule (nucleotides 1109-2241; see Fig. 1 ). The autoradiogram of the Southern blot was digitized using the MACSCAN program on a Macintosh IIx computer.
Scatchard Analysis of I1A4 Binding to Cell Lines. Binding of 125I-labeled IIIA4 to cell lines was performed in competition with unlabeled IIIA4 as described (20) .
RESULTS
Isolation and Characterization of cDNA Clones for HEK. One duplicating signal was obtained from screening -250,000 plaques of an LK63-derived AgtlO cDNA library under relaxed conditions with a degenerate 51-mer oligonucleotide. This plaque contained a 2.5-kb insert (HEK 2.5), which hybridized with a single 5.5-to 6.0-kb mRNA species in Northern blot analysis of cell lines expressing HEK-i.e., LK63 and JM (data not shown). PCR using HEK 2.5 and oligonucleotide primers based on conserved motifs within the catalytic domains of tyrosine kinases (15) gave DNA products of the appropriate size (data not shown). These results indicated HEK 2.5 was truncated at the 5' end. HEK 2.5 was used to rescreen the library under more stringent conditions and a 4.5-kb HEK (HEK 4.5) clone was isolated. This clone hybridized with a degenerate oligonucleotide based on the N-terminal protein sequence and produced DNA bands of the predicted sizes in PCRs using the primers referred to above (data not shown). These data indicated that the 4.5-kb clone probably contained the complete HEK coding region.
The sequence of the coding region for HEK, together with partial 3' and 5' untranslated sequence, is shown in Fig. 1 . An open reading frame of 2952 nucleotides extends from the initiation methionine at position 100 to the first termination codon at position 3051. Translation of the cDNA results in a predicted protein of 983 amino acids. There is identity between the amino acids obtained by sequencing the purified HEK protein and the predicted amino acid product of the cDNA clone (see Fig. 1 ). The predicted molecular mass ofthe translated protein (minus the putative signal peptide) is 92.8 kDa. This is in good agreement with previous results demonstrating a core protein of -95 kDa in both tunicamycin-and endoglycosidase-treated LK63 cells (11) .
The predicted protein product of the HEK cDNA clone has the features of a type la integral membrane protein (21) . Two predominantly hydrophobic regions indicate a putative signal peptide (amino acids 1-20) and a transmembrane segment (amino acids 542-565). The extracellular domain of 521 amino acids contains five possible sites for N-linked glycosylation. The N-terminal region (amino acids 21-376) of the extracellular domain is rich in cysteine residues. The C-terminal region (amino acids 326-511) of the extracellular domain contains two repeats homologous to those found in fibronectin type III (10) . The cytoplasmic domain (amino acids 566-983) of HEK contains the characteristic features of PTK catalytic domains, including a typical element of the ATPbinding site (GXGXXG), the DFG motif, and a putative site for tyrosine autophosphorylation at position 779 (2, 22) .
HEK has the following overall protein sequence identity with each of the four fully sequenced members of the EPH/ELK family: chicken CEK 5 (10), 56.4%; rat ELK (23), 56.1%; rat ECK (24), 50.6%; human EPH (25), 42.3%. Protein sequence alignment between HEK and a close relative, ELK, is shown in Fig. 2 . As expected, homology between these molecules is greatest within the catalytic domains. Outside the catalytic domains, there is conservation of a number of short motifs, which may have structural or functional significance. There is conservation of the number and spatial arrangement of cysteine residues within the extracellular domains of HEK, ELK, and other members of the EPH family (10) . These cysteine residues cluster within the N-ter- 
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HEK MSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE9IVSILDRLIRNPGS4KIITS7SNLLLDQS7ISTFRTTGDW7GVTACKEIFTGEYSSCDTIAKIS 947 minal portion of the extracellular domains (10) . The C-terminal regions of the extracellular domains contain repeats homologous to those found in fibronectin type 111 (10) . HEK has a cysteine in the C-terminal tail (amino acid 928), rather than the tyrosine, which is conserved in this position between other members of the EPH/ELK family. This may be significant in that phosphorylation of C-terminal tyrosine residues outside the catalytic domain can regulate tyrosine kinase activity (26) . However, HEK has a C-terminal tyrosine at position 937 and a number of other cytoplasmic tyrosine residues, which may be in context for autophosphorylation (27) .
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Transfection and Expression of HEK in COS Cells.
It was important to demonstrate that the cDNA clone isolated did indeed encode the molecule recognized by the IIIA4 mAb. HEK 4.5 was subcloned into the expression vector CDM8 and transfected into COS cells in both sense and antisense orientations. As shown in Fig. 3 performed Northern blot analysis with HEK 4.5 (Fig. 4) (1992) been affinity purified using the IIIA4 mAb. A degenerate 51-mer oligonucleotide based on the HEK amino acid sequence was used to screen a cDNA library derived from LK63. A 4.5-kb cDNA clone containing the complete HEK coding region was isolated, sequenced, and expressed in COS cells. The predicted translation product of the HEK cDNA clone has the structural features of a membrane-associated, receptor-type tyrosine kinase that is homologous to the EPH/ELK family of PTKs (23, 25) . Northern blot analysis showed restriction of HEK expression to the human lymphoid tumor cell lines LK63, JM, and HSB-2.
The intrinsic tyrosine kinase function and conservation of structural features of the tyrosine kinase domain have encouraged molecular strategies for the identification of additional PTKs. cDNAs encoding EPH (25) and related PTKs ELK (23), ECK (24), ERK and EEK (28) , and CEK 5 (10) were identified through molecular approaches and form a subfamily of RTKs. The members of this family that have been fully characterized to date (EPH, ELK, ECK, CEK 5, and HEK) are type la integral membrane proteins with highly conserved tyrosine catalytic domains. The extracellular domains of these molecules characteristically contain an N-terminal region that is rich in strictly conserved cysteine residues and a C-terminal region containing two fibronectin type 111-like repeats (10) . The functional significance of these structural features is not yet known.
In spite of highly conserved structural similarities, the pattern of expression for members of this family is quite distinct. A human EPH probe detected EPH mRNA transcripts in rat liver, lung, kidney, and testis and in human epithelial tumors (29) . ELK expression was limited to rat brain and testis (23) . ECK was expressed more widely, but it was most abundant in rat lung, skin, small intestine, and ovary as well as in epithelial cell lines (24) . Human ERK and EEK probes identified transcripts in rat lung and brain tissue, respectively (28) . CEK 5 protein was detected as early as day 2 in chicken embryos and at day 10 it was broadly expressed in embryonic tissues (10) . Expression of CEK 5 in embryonic brain gradually declined with development, whereas a rapid fall in CEK 5 expression in developing muscle was closely correlated with muscle differentiation. In adult chickens, CEK 5 was most abundant in brain, with lower levels in liver, intestine, and gizzard. A notable feature is the lack of reported expression of members of this family in hemopoietic or lymphoid tissues. This fact, together with the sequence differences apparent from alignment of HEK with ELK, ECK, and CEK 5, suggests that HEK is probably not the human equivalent of these molecules but is a bona fide addition to the EPH/ELK RTK family. The high degree of sequence conservation seen across members of the EPH/ ELK RTK family may suggest shared functional activities. However, the varied patterns of expression may also imply tissue-specific functions and ligands.
Overexpression of EPH has been documented in colonic, lung, and breast carcinomas (25) . There was no evidence for gene amplification or rearrangement ofthe EPH gene in these tumors. In addition, the sequence of EPH cloned from normal liver tissue was identical to that originally derived from a hepatoma cell line (29) . However, the in vitro overexpression of EPH in NIH 3T3 cells produced tumors when these cells were injected into nude mice (30) . These data suggest that the dysregulated expression of an otherwise normal member of the EPH/ELK RTK family may be oncogenic. Likewise, we found no evidence for HEK gene amplification or rearrangement in lymphoid tumor cell lines.
By analogy, aberrant HEK expression may contribute to the genesis of some human lymphoid tumors.
An extensive survey is required to document the pattern of HEK expression in normal and malignant human tissues. Also, whether overexpression of HEK gives rise to tumors in experimental animals remains to be determined. Given the expression of HEK in both pre-B and T-cell lines, HEK and its ligand may play physiological roles within the B-and T-cell lineages.
